Insight
Nature 458, 438-444 (26 March 2009) | doi:10.1038/nature07960; Published online 25 March 2009
Targeting the ubiquitin system in cancer therapy
Daniela Hoeller1 & Ivan Dikic2,3,4
Abstract
The ubiquitin system is a network of proteins dedicated to the ubiquitylation of cellular targets and the subsequent control of numerous cellular functions. The deregulation of components of this elaborate network leads to human pathogenesis, including the development of many types of tumour. Alterations in the ubiquitin system that occur during the initiation and progression of cancer are now being uncovered, and this knowledge is starting to be exploited for both molecular diagnostics and the development of novel strategies to combat cancer.
- Division of Medical Biochemistry, Innsbruck Medical University, Biocenter, Fritz-Pregl-Strasse 3, 6020 Innsbruck, Austria.
- Institute of Biochemistry II and Cluster of Excellence 'Macromolecular Complexes', Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.
- Tumor Biology Program, Mediterranean Institute for Life Sciences, 21000 Split, Croatia.
- Department of Immunology, School of Medicine, University of Split, Soltanska 2, 21000 Split, Croatia.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
DNA damage: ubiquitin marks the spotNature Structural & Molecular Biology News and Views (01 Jan 2008)
Marked for deathNature Cell Biology News and Views (01 May 2008)
Working out coupled monoubiquitinationNature Cell Biology News and Views (01 Nov 2006)
Linear polyubiquitylation: the missing link in NF?κB signallingNature Cell Biology News and Views (01 Feb 2009)


